Ignite Creation Date:
2025-12-24 @ 4:32 PM
Ignite Modification Date:
2025-12-25 @ 2:24 PM
Study NCT ID:
NCT03890666
Status:
COMPLETED
Last Update Posted:
2022-12-07
First Post:
2019-03-18
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-26
Start Date Type:
ACTUAL
Primary Completion Date:
2021-10-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-10-04
Completion Date Type:
ACTUAL
First Submit Date:
2019-03-18
First Submit QC Date:
None
Study First Post Date:
2019-03-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-09-29
Results First Submit QC Date:
None
Results First Post Date:
2022-10-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-05
Last Update Post Date:
2022-12-07
Last Update Post Date Type:
ACTUAL